A Novel Explainability Approach for Technology-Driven Translational Research on Brain Aging

Author:

Turnbull Adam12,Kaplan Robert M.3,Adeli Ehsan134,Lin Feng V.134

Affiliation:

1. Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA

2. School of Nursing, University of Rochester Medical Center, Rochester, NY, USA

3. Clinical Excellence Research Center (CERC), Stanford University, Stanford, CA, USA

4. Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA

Abstract

Brain aging leads to difficulties in functional independence. Mitigating these difficulties can benefit from technology that predicts, monitors, and modifies brain aging. Translational research prioritizes solutions that can be causally linked to specific pathophysiologies at the same time as demonstrating improvements in impactful real-world outcome measures. This poses a challenge for brain aging technology that needs to address the tension between mechanism-driven precision and clinical relevance. In the current opinion, by synthesizing emerging mechanistic, translational, and clinical research-related frameworks, and our own development of technology-driven brain aging research, we suggest incorporating the appreciation of four desiderata (causality, informativeness, transferability, and fairness) of explainability into early-stage research that designs and tests brain aging technology. We apply a series of work on electrocardiography-based “peripheral” neuroplasticity markers from our work as an illustration of our proposed approach. We believe this novel approach will promote the development and adoption of brain aging technology that links and addresses brain pathophysiology and functional independence in the field of translational research.

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference52 articles.

1. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease;Sevigny;Nature,2016

2. Alzheimer disease and aducanumab: Adjusting our approach;Selkoe;Nat Rev Neurol,2019

3. How does exercise reduce the rate of age-associated cognitive decline? A review of potential mechanisms;Kennedy;J Alzheimers Dis,2017

4. NIA-AA research framework: Toward a biological definition of Alzheimer’s disease;Jack;Alzheimers Dement,2018

5. A Critique of the 2018 National Institute on Aging’s. Research Framework: Toward a biological definition of Alzheimer’s disease;Garrett;Curr Neurobiol,2018

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Brain tumor image pixel segmentation and detection using an aggregation of GAN models with vision transformer;International Journal of Imaging Systems and Technology;2023-10-26

2. Autonomic nervous system flexibility for understanding brain aging;Ageing Research Reviews;2023-09

3. Improving comparability across cognitive training trials for brain aging: A focus on interoperability;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3